[Federal Register Volume 87, Number 178 (Thursday, September 15, 2022)]
[Notices]
[Page 56626]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19897]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-42-2022]


Foreign-Trade Zone (FTZ) 153--San Diego, California, Notification 
of Proposed Production Activity, Ajinomoto Bio-Pharma Services 
(Pharmaceutical Products), San Diego, California

    The City of San Diego, grantee of FTZ 153, submitted a notification 
of proposed production activity to the FTZ Board (the Board) on behalf 
of Ajinomoto Bio-Pharma Services, located in San Diego, California 
under FTZ 153. The notification conforming to the requirements of the 
Board's regulations (15 CFR 400.22) was received on September 7, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz.
    The proposed finished product is yusimry--(active pharmaceutical 
ingredient (API) substance and packaging into measured doses in vials 
and/or syringes) (duty-free).
    The proposed foreign-status material and component is yusimry API 
substance (duty-free).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is October 25, 
2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: September 9, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022-19897 Filed 9-14-22; 8:45 am]
BILLING CODE 3510-DS-P